SCHEMBL5487192

SCHEMBL5487192

O=[N+](O)c1cccc(OP(=O)([O-])O)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 2/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
CA1 P00915 2/20 0.38
CA2 P00918 1/20 0.38
CES2 O00748 1/20 0.38
CES1 P23141 1/20 0.38
NPSR1 Q6W5P4 1/20 0.36
F2 P00734 1/20 0.35
ACP3 P15309 1/20 0.35
CA12 O43570 1/20 0.35
MMP2 P08253 1/20 0.35
PTPRC P08575 1/20 0.35
TSHR P16473 2/20 0.34
LMNA P02545 1/20 0.34
GPR84 Q9NQS5 1/20 0.34
CHRNB2 P17787 1/20 0.34
CHRNA4 P43681 1/20 0.34
ALDH1A1 P00352 1/20 0.33
ALOX15 P16050 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9096017 0.81 SRC (0.39) SRCMEN1KMT2ACA1CA2
SCHEMBL35321 0.79 CA1 (0.55) SRCMEN1KMT2ACA1CA2
SCHEMBL3733671 0.77 CA1 (0.53) SRCMEN1KMT2ACA1CA2
SCHEMBL11322611 0.77 CA1 (0.53) SRCMEN1KMT2ACA1CA2
SCHEMBL1759204 0.75 CA1 (0.64) SRCMEN1KMT2ACA1CA2
SCHEMBL6006252 0.75 CES2 (0.64) MEN1KMT2ACA1CA2CES2
SCHEMBL1759207 0.75 CA1 (0.64) SRCMEN1KMT2ACA1CA2
SCHEMBL2637263 0.74 TSHR (0.38) MEN1KMT2ACA1CA2CES2
SCHEMBL4535384 0.71 PDE7A (0.38) MEN1KMT2ACA1CA2CES2
SCHEMBL17347353 0.71 TSHR (0.55) MEN1KMT2ACA1CA2CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070081984-A1 Compositions and methods for treating hypophosphatasia SAINT LOUIS UNIVERSITY 2007-04-12 US disclosed
WO-2005114197-A2 ACTIVITY-BASED PROBES FOR PROTEIN TYROSINE PHOSPHATASES ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) 2005-12-01 WO disclosed
EP-1363930-A4 A METHOD FOR GENERATING GENETICALLY ALTERED ANTIGENS MORPHOTEK INC (US) 2004-04-14 EP disclosed
EP-1363930-A1 A METHOD FOR GENERATING GENETICALLY ALTERED ANTIGENS Morphotek Inc. (US) 2003-11-26 EP disclosed
WO-2002057311-A9 SPHINGOSINE 1-PHOSPHATE RECEPTOR GENE, SPPR UNIV SOUTH FLORIDA (US) 2003-09-12 WO disclosed
WO-2002040499-A1 A METHOD FOR GENERATING GENETICALLY ALTERED ANTIGENS MORPHOTEK INC. (US) 2002-05-23 WO disclosed
WO-2002030968-A1 NOVEL MITE ALLERGENS AND USES THEREFOR NATIONAL UNIVERSITY OF SINGAPORE (SG) 2002-04-18 WO disclosed
US-6143088-A A PHTHALAMIDOALKYL PERACID, AN ALKANEDIOIC PERACID OR SALTS AND A CATIONIC QUATERNARY AMMONIUM SURFACTANT; CLEANING WITHOUT DEGRADATION OF MATERIALS SOILED BY TOXIC AGENTS, SUCH AS ORGANOPHOSPHATES AND -SULFUR COMPOUNDS, E.G. VX, YPERITE Etat Francais represented by the Delegue General pour l ' Armement (FR) 2000-11-07 US disclosed
EP-0812330-A2 PEPTIDYL COMPOUNDS COMPRISING AN ITIM MOTIF WHICH REGULATE HEMATOPOIETIC FUNCTION AND THEIR USE NATIONAL JEWISH CENTER FOR IMMUNOLOGY AND RESPIRATORY MEDICINE (US) 1997-12-17 EP disclosed
WO-1997035016-A1 POLYPEPTIDES HAVING PHYTASE ACTIVITY AND NUCLEIC ACIDS ENCODING SAME NOVO NORDISK BIOTECH INC (US) 1997-09-25 WO disclosed
WO-1996026961-A2 PEPTIDYL COMPOUNDS COMPRISING AN ITIM MOTIF WHICH REGULATE HEMATOPOIETIC FUNCTION AND THEIR USE NATIONAL JEWISH CENTER FOR IMMUNOLOGY AND RESPIRATORY MEDICINE (US) 1996-09-06 WO disclosed